S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Closing prices for crude oil, gold and other commodities
The Senate passes a reauthorization of a key US surveillance program just after a midnight deadline
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?

Vicarious Surgical (RBOT) Earnings Date, Estimates & Call Transcripts

$0.29
+0.01 (+3.60%)
(As of 04/19/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Apr. 29
After Market Closes
Confirmed
Actual EPS
(Mar. 4)
-$0.07 Beat By $0.05
Consensus EPS
(Mar. 4)
-$0.12
Skip Charts & View Estimated and Actual Earnings Data

RBOT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RBOT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vicarious Surgical Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.39) EPS
Next Year EPS Consensus Estimate: ($0.41) EPS

RBOT Earnings Date and Information

Vicarious Surgical last issued its earnings results on March 4th, 2024. The reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.05. Vicarious Surgical has generated ($0.49) earnings per share over the last year (($0.49) diluted earnings per share). Earnings for Vicarious Surgical are expected to decrease in the coming year, from ($0.39) to ($0.41) per share. Vicarious Surgical has confirmed that its next quarterly earnings report will be published on Monday, April 29th, 2024. Vicarious Surgical will be holding an earnings conference call on Monday, April 29th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Vicarious Surgical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/29/2024
Confirmed)
-------  
3/4/2024Q4 2023($0.12)($0.07)+$0.05($0.08)--    
11/13/2023Q3 2023($0.15)($0.12)+$0.03($0.14)--
7/27/2023Q2 2023($0.13)($0.16)($0.03)($0.20)--
5/8/2023Q1 2023($0.09)($0.17)($0.08)($0.13)--    
2/13/2023Q4 2022($0.18)($0.16)+$0.02($0.23)--    
11/7/2022Q3 2022($0.15)($0.18)($0.03)($0.16)--  
8/8/2022Q2 2022($0.14)($0.16)($0.02)($0.31)--
5/9/2022Q1 2022($0.13)($0.15)($0.02)($0.63)--
3/3/2022Q4 2021($0.11)($0.15)($0.04)($0.89)--    
11/8/2021Q3 2021($0.04)($0.09)($0.05)$0.53--    

Vicarious Surgical Earnings - Frequently Asked Questions

When is Vicarious Surgical's earnings date?

Vicarious Surgical has confirmed that its next quarterly earnings data will be published on Monday, April 29th, 2024. Learn more on RBOT's earnings history.

Did Vicarious Surgical beat their earnings estimates last quarter?

In the previous quarter, Vicarious Surgical (NYSE:RBOT) reported ($0.07) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.12) by $0.05. Learn more on analysts' earnings estimate vs. RBOT's actual earnings.

How can I listen to Vicarious Surgical's earnings conference call?

The conference call for Vicarious Surgical's latest earnings report can be listened to online. Listen to Conference Call

How can I read Vicarious Surgical's conference call transcript?

The conference call transcript for Vicarious Surgical's latest earnings report can be read online. Read Transcript

How much profit does Vicarious Surgical generate each year?

Vicarious Surgical (NYSE:RBOT) has a recorded net income of -$71.07 million. RBOT has generated -$0.49 earnings per share over the last four quarters.

What is Vicarious Surgical's EPS forecast for next year?

Vicarious Surgical's earnings are expected to decrease from ($0.39) per share to ($0.41) per share in the next year.


More Earnings Resources from MarketBeat

This page (NYSE:RBOT) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners